IMB Dx, Inc.
AlphaLiquid - Model 1000 -Cancer-Related Genes
FromIMB Dx, Inc.
AlphaLiquid®1000 is a pan-cancer assay for almost all known types of solid cancer patients, designed to examine more than a 1000 genes related to different cancers at once. It, too, can be used in companion diagnostics to detect and monitor signs of relapse and/or metastasis after beginning anticancer drug therapy.
Most popular related searches
cancer genetic
drug therapy
pancreatic prostate
tumor mutation
cancer patient
drug target
metastasis
pancreatic stomach
prostate
pancreas
Target cancers
Colorectal, lung, breast, ovarian, stomach, pancreatic, prostate, brain, skin, thyroid, and most other cancers
Detectable mutations
SNV, Indel, fusion, CNV, MSI + TMB(tumor mutational burden)